title: Indoleamine 2,3-dioxygenase in human hematopoietic stem cell transplantation.
abstract: In recent years tryptophan metabolism and its rate limiting enzyme indoleamine 2,3-dioxygenase (IDO) have attracted increasing attention for their potential to modulate immune responses including the regulation of transplantation tolerance. The focus of this review is to discuss some features of IDO activity which particularly relate to hematopoietic stem cell transplantation (HSCT). HSCT invariably involves the establishment of some degree of a donor-derived immune system in the recipient. Thus, the outstanding feature of tolerance in HSCT is that in this type of transplantation it is not rejection, which causes the most severe problems to HSCT recipients, but the reverse, graft-versus-host (GvH) directed immune responses. We will discuss the peculiar role of IDO activity and accelerated tryptophan metabolism at the interface between immune activation and immune suppression and delineate from theoretical and experimental evidence the potential significance of IDO in mediating tolerance in HSCT. Finally, we will examine therapeutic options for exploitation of IDO activity in the generation of allo-antigen-specific tolerance, i.e. avoiding allo-reactivity while maintaining immunocompetence, in HSCT.
authors.affiliation: Children's Cancer Research Institute, Division Transplantation Immunology, Zimmermannplatz 10, A-1090 Vienna, Austria.
authors.forename: Birgit
authors.initials: B
authors.lastname: Jürgens
authors.forename: Julia
authors.initials: J
authors.lastname: Raberger
authors.forename: Dietmar
authors.initials: D
authors.lastname: Fuchs
authors.forename: Andreas
authors.initials: A
authors.lastname: Heitger
references.citation: Int J Immunogenet. 2008 Aug;35(4-5):375-80
references.pmid: 18976441
references.citation: Cancer Lett. 2005 Jun 8;223(2):323-9
references.pmid: 15896467
references.citation: J Clin Invest. 2004 Jul;114(2):280-90
references.pmid: 15254595
references.citation: Nat Immunol. 2008 Dec;9(12):1399-406
references.pmid: 18978793
references.citation: J Invest Dermatol. 2004 Apr;122(4):953-64
references.pmid: 15102086
references.citation: Blood. 2005 May 15;105(10):4127-34
references.pmid: 15677560
references.citation: Proc Natl Acad Sci U S A. 1972 Jul;69(7):1800-3
references.pmid: 4505657
references.citation: Blood. 2008 Mar 15;111(6):3257-65
references.pmid: 18077788
references.citation: Biol Blood Marrow Transplant. 2009 Nov;15(11):1347-53
references.pmid: 19822293
references.citation: J Immunol. 1996 Jun 15;156(12):4609-16
references.pmid: 8648103
references.citation: Scand J Immunol. 2003 Feb;57(2):185-91
references.pmid: 12588666
references.citation: Blood. 2009 Dec 3;114(24):5062-70
references.pmid: 19828695
references.citation: Blood. 2000 Sep 15;96(6):2299-303
references.pmid: 10979980
references.citation: Cell Death Differ. 2002 Oct;9(10):1069-77
references.pmid: 12232795
references.citation: Nat Rev Immunol. 2007 Oct;7(10):817-23
references.pmid: 17767193
references.citation: Immunity. 2005 May;22(5):633-42
references.pmid: 15894280
references.citation: Stem Cells Dev. 2007 Oct;16(5):797-810
references.pmid: 17999601
references.citation: Nat Rev Immunol. 2005 Aug;5(8):641-54
references.pmid: 16056256
references.citation: FASEB J. 2005 Dec;19(14):1957-68
references.pmid: 16319139
references.citation: Bone Marrow Transplant. 2008 Jun;41 Suppl 2:S58-64
references.pmid: 18545246
references.citation: Annu Rev Med. 2003;54:29-52
references.pmid: 12359826
references.citation: Transpl Int. 2007 Feb;20(2):118-27
references.pmid: 17239019
references.citation: Leukemia. 2008 Mar;22(3):593-9
references.pmid: 18185520
references.citation: J Immunol. 1998 Mar 1;160(5):2059-64
references.pmid: 9498741
references.citation: J Leukoc Biol. 2007 Oct;82(4):887-93
references.pmid: 17609339
references.citation: FASEB J. 2009 Sep;23(9):3070-7
references.pmid: 19420134
references.citation: Blood. 1997 Jul 15;90(2):850-7
references.pmid: 9226186
references.citation: J Immunol. 2006 Mar 1;176(5):2857-63
references.pmid: 16493042
references.citation: Immunology. 1989 Sep;68(1):18-23
references.pmid: 2509325
references.citation: Best Pract Res Clin Haematol. 2007 Jun;20(2):171-87
references.pmid: 17448955
references.citation: Blood. 1987 Feb;69(2):369-80
references.pmid: 3542077
references.citation: J Clin Invest. 2008 Jul;118(7):2562-73
references.pmid: 18568076
references.citation: J Clin Invest. 2007 Sep;117(9):2570-82
references.pmid: 17710230
references.citation: Blood. 2008 Aug 1;112(3):532-41
references.pmid: 18445691
references.citation: Nat Immunol. 2003 Oct;4(10):957-64
references.pmid: 14502285
references.citation: Blood. 2006 Jul 1;108(1):228-37
references.pmid: 16522817
references.citation: Clin Exp Immunol. 2007 Aug;149(2):353-63
references.pmid: 17521318
references.citation: Trends Immunol. 2006 Apr;27(4):183-7
references.pmid: 16527542
references.citation: Blood. 2008 Feb 1;111(3):1327-33
references.pmid: 17951526
references.citation: Blood. 1998 Dec 1;92(11):4464-71
references.pmid: 9834254
references.citation: Immunology. 2002 Dec;107(4):452-60
references.pmid: 12460190
references.citation: J Clin Invest. 2008 Oct;118(10):3431-9
references.pmid: 18776940
references.citation: J Acquir Immune Defic Syndr (1988). 1990;3(9):873-6
references.pmid: 2166783
references.citation: Nat Rev Immunol. 2007 Dec;7(12):942-53
references.pmid: 18007679
references.citation: J Clin Invest. 1998 Dec 15;102(12):2126-35
references.pmid: 9854048
references.citation: Transplantation. 1994 Dec 27;58(12):1385-93
references.pmid: 7809932
references.citation: Blood. 2006 Oct 1;108(7):2265-74
references.pmid: 16741252
references.citation: Curr Drug Metab. 2007 Apr;8(3):209-16
references.pmid: 17430109
references.citation: Blood. 2007 Jan 1;109(1):228-34
references.pmid: 16985180
references.citation: Blood. 2004 Jun 1;103(11):4232-9
references.pmid: 14982877
references.citation: Lancet. 2008 May 10;371(9624):1579-86
references.pmid: 18468541
references.citation: Nature. 2007 Oct 4;449(7162):557-63
references.pmid: 17914389
references.citation: Nat Med. 2007 May;13(5):579-86
references.pmid: 17417651
references.citation: J Immunol. 2001 Jan 15;166(2):973-81
references.pmid: 11145675
references.citation: J Immunol. 2006 Jun 1;176(11):6752-61
references.pmid: 16709834
references.citation: Microbes Infect. 2009 Jan;11(1):133-41
references.pmid: 19007906
references.citation: J Exp Med. 2005 Jun 20;201(12):1925-35
references.pmid: 15967822
references.citation: J Exp Med. 1990 Dec 1;172(6):1735-9
references.pmid: 2147950
references.citation: Leukemia. 2003 Oct;17(10):1934-42
references.pmid: 14513041
references.citation: Nat Rev Immunol. 2007 May;7(5):340-52
references.pmid: 17438575
references.citation: Blood. 2002 Dec 15;100(13):4358-66
references.pmid: 12393425
references.citation: Trends Immunol. 2008 Oct;29(10):479-86
references.pmid: 18775671
references.citation: J Immunol. 1996 Sep 1;157(5):1935-43
references.pmid: 8757312
references.citation: Neoplasia. 2005 Apr;7(4):390-6
references.pmid: 15967116
references.citation: Eur J Immunol. 1993 Feb;23(2):333-7
references.pmid: 8436168
references.citation: Blood. 2009 May 14;113(20):5002-9
references.pmid: 19258593
references.citation: Immunol Cell Biol. 2008 Jul;86(5):460-5
references.pmid: 18332894
references.citation: J Immunol. 2008 Oct 15;181(8):5396-404
references.pmid: 18832696
references.citation: Blood. 2005 Feb 15;105(4):1815-22
references.pmid: 15494428
references.citation: Blood. 2005 Apr 1;105(7):2821-7
references.pmid: 15591115
references.citation: Int J Tryptophan Res. 2009;2:1-19
references.pmid: 22084578
references.citation: Xenotransplantation. 2008 May-Jun;15(3):174-83
references.pmid: 18611225
references.citation: Arthritis Res Ther. 2005;7(2):R402-15
references.pmid: 15743488
references.citation: Eur J Immunol. 2006 Jan;36(1):12-20
references.pmid: 16323249
references.citation: J Immunol. 2004 Jul 1;173(1):542-9
references.pmid: 15210815
references.citation: Bone Marrow Transplant. 2007 Jun;39(11):711-6
references.pmid: 17417662
references.citation: Trends Immunol. 2003 May;24(5):242-8
references.pmid: 12738417
references.citation: Adv Exp Med Biol. 1991;294:437-44
references.pmid: 1772076
references.citation: Eur J Immunol. 2007 Nov;37(11):3054-62
references.pmid: 17948274
references.citation: Annu Rev Immunol. 1997;15:749-95
references.pmid: 9143706
references.citation: J Exp Med. 1999 May 3;189(9):1363-72
references.pmid: 10224276
references.citation: Blood. 2009 Jan 1;113(1):46-57
references.pmid: 18832657
references.citation: Cancer Immunol Immunother. 2005 Aug;54(8):769-80
references.pmid: 15647926
references.citation: Nat Rev Immunol. 2004 Oct;4(10):762-74
references.pmid: 15459668
references.citation: Nat Med. 2009 Jan;15(1):42-9
references.pmid: 19098906
references.citation: Curr Hematol Rep. 2003 Jul;2(4):287-94
references.pmid: 12901325
references.citation: Eur J Immunol. 2007 Apr;37(4):876-9
references.pmid: 17393386
references.citation: Blood. 2009 Oct 1;114(14):3101-12
references.pmid: 19602708
references.citation: J Exp Med. 2002 Aug 19;196(4):447-57
references.pmid: 12186837
references.citation: PLoS One. 2008 Aug 13;3(8):e2961
references.pmid: 18698365
references.citation: Blood. 2007 Nov 15;110(10):3691-4
references.pmid: 17684157
references.citation: Blood. 2009 Apr 9;113(15):3612-9
references.pmid: 19211507
references.citation: Science. 1995 Jun 9;268(5216):1476-80
references.pmid: 7539551
references.citation: Nat Immunol. 2002 Nov;3(11):1056-7
references.pmid: 12407416
references.citation: Immunol Rev. 1997 Jun;157:61-72
references.pmid: 9255622
references.citation: Science. 1998 Aug 21;281(5380):1191-3
references.pmid: 9712583
references.citation: Blood. 2009 Oct 8;114(15):3235-43
references.pmid: 19625705
references.citation: Blood. 2008 Mar 15;111(6):3286-94
references.pmid: 18178869
references.citation: Leukemia. 2005 Sep;19(9):1597-604
references.pmid: 16049516
references.citation: Blood. 2004 Jun 15;103(12):4619-21
references.pmid: 15001472
references.citation: Mol Pharmacol. 2004 Jul;66(1):122-8
references.pmid: 15213303
references.citation: Nat Rev Immunol. 2008 Sep;8(9):726-36
references.pmid: 19172693
references.citation: Blood. 2009 May 28;113(22):5689-91
references.pmid: 19478054
references.citation: Nat Immunol. 2003 Dec;4(12):1206-12
references.pmid: 14578884
references.citation: Biol Blood Marrow Transplant. 2007 Jan;13(1):46-55
references.pmid: 17222752
references.citation: Curr Drug Metab. 2007 Apr;8(3):273-82
references.pmid: 17430115
references.citation: Hum Immunol. 1996 Jun-Jul;48(1-2):135-8
references.pmid: 8824582
references.citation: Nat Med. 2003 Oct;9(10):1269-74
references.pmid: 14502282
references.citation: Nat Rev Immunol. 2003 Feb;3(2):147-58
references.pmid: 12563298
references.citation: Int Rev Immunol. 2009;28(3-4):185-206
references.pmid: 19811321